BOAA
BMY icon

Bank of Ann Arbor’s Bristol-Myers Squibb BMY Stock Holding History

Bank of Ann Arbor’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.49M Buy
+39,848
New +$2.52M 0.35% 62

Other funds holding BMY

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Independent Franchise Partners
Independent Franchise Partners London, United Kingdom $16.1B AUM 4.39% 1-Year Est. Return

Bank of Ann Arbor's BMY Position: Q3 2026 in Review

Bank of Ann Arbor opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 39,848 shares worth $2.49M. The stake represents 0.35% of the portfolio and ranks #62 among its holdings.

2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Bank of Ann Arbor held 39,848 shares of Bristol-Myers Squibb worth $2.49M as of Q3 2026.
  • Bristol-Myers Squibb was a new Bank of Ann Arbor position in Q3 2026.
  • Bristol-Myers Squibb made up 0.35% of Bank of Ann Arbor's portfolio in Q3 2026, its #62 holding.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Bank of Ann Arbor's 13F filing for Q3 2026, filed 13 Nov 2026.